Drug intelligence / Profile preview

JOINTFOL-PLUS

Development stage
Unknown
Lead developer
Jointcare Pharmaceuticals
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral
01

Overview

JOINTFOL-PLUS is a branded neurotropic nutritional supplement developed and marketed by Jointcare Pharmaceuticals Pvt Ltd. Formulated as an oral capsule, it contains a combination of Methylcobalamin (1500 mcg), Thiamine Mononitrate (10 mg), Folic Acid (1.5 mg), Pyridoxine Hydrochloride (3 mg), and Alpha Lipoic Acid (100 mg). The product is specifically designed to support nerve health and function, acting as a 'neuron protector and rejuvenator.' Its primary clinical applications include the management of neuropathic pain—particularly diabetic neuropathy—as well as the treatment of nutritional deficiencies, anemia, and various neurological conditions. By providing essential B-vitamins and the antioxidant alpha-lipoic acid, JOINTFOL-PLUS promotes myelin sheath synthesis, nerve regeneration, and energy metabolism while protecting neural tissues from oxidative damage. Although the developer specializes in orthopedic treatments, this specific formulation is indicated for neurological and metabolic support rather than direct joint care.

Brand names
JOINTFOL-PLUS
02

Targets

TKT (Transketolase)MTR (Methionine synthase)PDH (Pyruvate dehydrogenase complex)

Beyond the preview

Go deeper on JOINTFOL-PLUS.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on JOINTFOL-PLUS.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call